Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and in vitro cellular studies

References

• Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock. Lancet. 2018;392(10141):75–87.
   PubMed Web of Science ®Google Scholar
• Lopez N, Kobayashi L, Coimbra R. A comprehensive review of abdominal infections. World J Emerg Surg. 2011;6(1):1–10.
   PubMedGoogle Scholar
• Sartelli M, Catena F, Ansaloni L, et al. Complicated intra-abdominal infections in a worldwide context: an observational prospective study (CIAOW study). World J Emerg Surg. 2013;8(1):1–8.
   PubMedGoogle Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Vol. 43, Intensive Care Medicine. Berlin Heidelberg: Springer; 2017. p. 304–377.
   Google Scholar
• Cunha BA. Sepsis and septic shock: selection of empiric antimicrobial therapy. Crit Care Clin. 2008;24(2):313–334.
   PubMedGoogle Scholar
• Malangoni MA, Song J, Herrington J, et al. Randomized controlled trial of moxifloxacin compared with piperacillin–tazobactam and amoxicillin–clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg. 2006;244(2):204–211.
   PubMed Web of Science ®Google Scholar
• Shalit I, Halperin D, Haite D, et al. Anti-inflammatory effects of moxifloxacin on IL-8, IL-1β and TNF-α secretion and NFkB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus. J Antimicrob Chemother. 2006;57(2):230–235.
   PubMedGoogle Scholar
• Shukla P, Rao GM, Pandey G, et al. Therapeutic interventions in sepsis: current and anticipated pharmacological agents. Br J Pharmacol. 2014;171(22):5011–5031.
   PubMed Web of Science ®Google Scholar
• Hayashi PH, Chalasani NP. Liver injury in the elderly due to fluoroquinolones: should these drugs be avoided? CMAJ. 2012;184(14):1555–1556.
   PubMedGoogle Scholar
• Verma R, Dhamija R, Batts DH, et al. Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report. Cases J. 2009;2(1):8063.
   PubMedGoogle Scholar
• Hou X, Zhang X, Zhao W, et al. Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis. Nat Nanotechnol. 2020;15(1):41–46.
   PubMed Web of Science ®Google Scholar
• Liu J, Ding H, Zhao M, et al. Functionalized erythrocyte membrane-coated nanoparticles for the treatment of Klebsiella pneumoniae-induced sepsis. Front Microbiol. 2022;13:901979.
   PubMedGoogle Scholar
• Chen G, Xu Y. Biosynthesis of cerium oxide nanoparticles and their effect on lipopolysaccharide (LPS) induced sepsis mortality and associated hepatic dysfunction in male Sprague Dawley rats. Mater Sci Eng C. 2018;83:148–153.
   PubMedGoogle Scholar
• Lu S, Zhou S, Chen J, et al. Quercetin nanoparticle ameliorates lipopolysaccharide-triggered renal inflammatory impairment by regulation of Sirt1/NF-KB pathway. J Biomed Nanotechnol. 2021;17(2):230–241.
   PubMedGoogle Scholar
• Sur S, Rathore A, Dave V, et al. Recent developments in functionalized polymer nanoparticles for efficient drug delivery system. Nano Struct Nano Obj. 2019;20:100397.
   Google Scholar
• Salvi V, Pawar P. Eudragit RL100 based moxifloxacin hydrochloride and ketorolac tromethamine combination nanoparticulate system for ocular drug delivery. Pharm Nanotechnol. 2020;8(2):133–147.
   PubMedGoogle Scholar
• Kashyap K, Handa M, Shukla R. Azacitidine loaded PLGA nanoparticles and their dual release mechanism. CNANOM. 10(3):280–289.
   Google Scholar
• Jin S, Xia X, Huang J, et al. Recent advances in PLGA-based biomaterials for bone tissue regeneration. Acta Biomater. 2021;127:56–79.
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102.
   PubMed Web of Science ®Google Scholar
• Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935–947.
   PubMed Web of Science ®Google Scholar
• Yong JM, Mantaj J, Cheng Y, et al. Delivery of nanoparticles across the intestinal epithelium via the transferrin transport pathway. Pharmaceutics. 2019;11(7):298.
   PubMed Web of Science ®Google Scholar
• Hernández-Giottonini KY, Rodríguez-Córdova RJ, Gutiérrez-Valenzuela CA, et al. PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC Adv. 2020;10(8):4218–4231.
   PubMed Web of Science ®Google Scholar
• Chang J, Paillard A, Passirani C, et al. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Pharm Res. 2012;29(6):1495–1505.
   PubMed Web of Science ®Google Scholar
• Alihosseini F, Ghaffari S, Dabirsiaghi AR, et al. Freeze-drying of ampicillin solid lipid nanoparticles using mannitol as cryoprotectant. Braz J Pharm Sci. 2015;51(4):797–802.
   Web of Science ®Google Scholar
• Bhattacharjee S. DLS and zeta potential – what they are and what they are not? J Control Release. 2016;235:337–351.
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999;57(2):171–185.
   PubMed Web of Science ®Google Scholar
• Handa M, Sharma A, Verma RK, et al. Polycaprolactone based nano-carrier for co-administration of moxifloxacin and rutin and its in-vitro evaluation for sepsis. J Drug Deliv Sci Technol. 2019;54:101286.
   Web of Science ®Google Scholar
• Ruiz-Sorribas A, Poilvache H, van Bambeke F. Pharmacodynamics of moxifloxacin, meropenem, caspofungin, and their combinations against in vitro polymicrobial interkingdom biofilms. Antimicrob Agents Chemother. 2022;66(2):e0214921 (1-17).
   Google Scholar
• Santos AC, Caldas M, Pattekari P, et al. Layer-by-layer coated drug-core nanoparticles as versatile delivery platforms. In: Design and development of new nanocarriers; 2018. p. 595–635.
   Google Scholar
• Mustafa S, Devi VK, Pai RS. Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. Drug Deliv Transl Res. 2017;7(1):27–36.
   PubMed Web of Science ®Google Scholar
• Frasco MF, Almeida GM, Santos-Silva F, et al. Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells. J Biomed Mater Res A. 2015;103(4):1476–1484.
   PubMedGoogle Scholar
• Singh N, Handa M, Singh V, et al. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target. 2022;30:1–17.
   PubMedGoogle Scholar
• Vandervoort J, Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int J Pharm. 2002;238:1–2.
   PubMedGoogle Scholar
• Menon JU, Kona S, Wadajkar AS, et al. Effects of surfactants on the properties of PLGA nanoparticles. J Biomed Mater Res A. 2012;100(8):1998–2005.
   PubMed Web of Science ®Google Scholar
• Zhang S, Hu W, Yuan L, et al. Transferrin receptor 1 is a supplementary receptor that assists transmissible gastroenteritis virus entry into porcine intestinal epithelium. Cell Commun Signal. 2018;16(1):1–11.
   PubMedGoogle Scholar
• Ramalho MJ, Bravo M, Loureiro JA, et al. Transferrin-modified nanoparticles for targeted delivery of asiatic acid to glioblastoma cells. Life Sci. 2022;296:120435.
   PubMed Web of Science ®Google Scholar
• Jose S, Cinu TA, Sebastian R, et al. Transferrin-conjugated docetaxel–PLGA nanoparticles for tumor targeting: influence on MCF-7 cell cycle. Polymers. 2019;11(11):1905.
   PubMed Web of Science ®Google Scholar
• Siu FYK, Ye S, Lin H, et al. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity. Int J Nanomedicine. 2018;13:4133–4144.
   PubMed Web of Science ®Google Scholar
• Bhatt P, Fnu G, Bhatia D, et al. Nanodelivery of resveratrol-loaded PLGA nanoparticles for age-related macular degeneration. AAPS PharmSciTech. 2020;21(8):291.
   PubMed Web of Science ®Google Scholar
• Delan WK, Zakaria M, Elsaadany B, et al. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: optimization using Box–Behnken design, stability and in vivo study. Int J Pharm. 2020;577:119038.
   PubMed Web of Science ®Google Scholar
• Vakilinezhad MA, Amini A, Dara T, et al. Methotrexate and curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: in vitro and in vivo evaluation. Colloids Surf B Biointerfaces. 2019;184:110515.
   PubMed Web of Science ®Google Scholar
• Shah S, Cristopher D, Sharma S, et al. Inhalable linezolid loaded PLGA nanoparticles for treatment of tuberculosis: design, development and in vitro evaluation. J Drug Deliv Sci Technol. 2020;60:102013.
   Google Scholar
• Scheeren LE, Nogueira-Librelotto DR, Macedo LB, et al. Transferrin-conjugated doxorubicin-loaded PLGA nanoparticles with pH-responsive behavior: a synergistic approach for cancer therapy. J Nanopart Res. 2020;22(3).
   Google Scholar
• Davoudi Z, Peroutka-Bigus N, Bellaire B, et al. Gut organoid as a new platform to study alginate and chitosan mediated PLGA nanoparticles for drug delivery. Mar Drugs. 2021;19(5):282.
   PubMedGoogle Scholar
• Yoo J, Won YY. Phenomenology of the initial burst release of drugs from PLGA microparticles. ACS Biomater Sci Eng. 2020;6(11):6053–6062.
   PubMed Web of Science ®Google Scholar
• Sufi SA, Hoda M, Pajaniradje S, et al. Enhanced drug retention, sustained release, and anti-cancer potential of curcumin and indole-curcumin analog-loaded polysorbate 80-stabilizied PLGA nanoparticles in colon cancer cell line SW480. Int J Pharm. 2020;588:119738.
   PubMedGoogle Scholar
• Anwer MK, Mohammad M, Ezzeldin E, et al. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nanomedicine. 2019;14:1587–1595.
   PubMed Web of Science ®Google Scholar
• Aguilera-Correa JJ, Gisbert-Garzarán M, Mediero A, et al. Arabic gum plus colistin coated moxifloxacin-loaded nanoparticles for the treatment of bone infection caused by Escherichia coli. Acta Biomater. 2022;137:218–237.
   PubMed Web of Science ®Google Scholar
• Zafar A, Alsaidan OA, Imam SS, et al. Formulation and evaluation of moxifloxacin loaded bilosomes in-situ gel: optimization to antibacterial evaluation. Gels. 2022;8(7):418.
   PubMed Web of Science ®Google Scholar
• Ibrahim WN, Rosli LMBM, Doolaanea AA. Formulation, cellular uptake and cytotoxicity of thymoquinone-loaded PLGA nanoparticles in malignant melanoma cancer cells. Int J Nanomedicine. 2020;15:8059–8074.
   PubMed Web of Science ®Google Scholar
• Wan S, Zhang L, Quan Y, et al. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. R Soc Open Sci. 2018;5(11):181457.
   PubMed Web of Science ®Google Scholar
• Soni M, Handa M, Singh KK, et al.Recent nanoengineered diagnostic and therapeutic advancements in management of sepsis. J. Controlled Release. 2022;352:931–945.
   PubMedGoogle Scholar